Physician profile
Morgan Biggs
NPI 1972124998
$2,296.69
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.47 · 2021: $1,017 · 2022: $508 · 2023: $468 · 2024: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $426.37 | 2020-2024 | Perseris |
| Neurocrine Biosciences, INC. | $353.56 | 2020-2021 | |
| Abbvie INC. | $341.96 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $338.92 | 2021-2023 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $284.12 | 2021-2022 | |
| Alkermes, INC. | $171.65 | 2022-2024 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $164.21 | 2021-2024 | Invega Sustenna |
| Almatica Pharma LLC | $126.58 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $89.32 | 2021-2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Biggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.